Free Trial
NASDAQ:EYEG

AB Corporate Bond ETF (EYEG) Price, Holdings, & News

AB Corporate Bond ETF logo
$33.46 -0.01 (-0.03%)
As of 03:52 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About AB Corporate Bond ETF (NASDAQ:EYEG)

Advanced

Key Stats

Today's Range
$33.45
▼
$33.45
50-Day Range
$33.20
▼
$34.70
52-Week Range
$33.24
▼
$36.63
Volume
128 shs
Average Volume
311 shs
Market Capitalization
$26.77 million
Assets Under Management
$26.76 million
Dividend Yield
N/A
Net Expense Ratio
0.30%
Aggregate Rating
N/A

ETF Overview

EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

AB Corporate Bond ETF Expenses

TypeEYEGInvestment Grade ETFsFixed Income ETFsNASDAQ ETFsAll ETFs
Management Fee0.30%0.22%0.31%0.54%0.53%
Other Expenses0.00%0.10%0.31%0.38%0.54%
Total Expense0.30%0.25%0.41%0.69%0.73%
Fee Waiver0.00%-0.14%-0.35%-0.41%-0.68%
Net Expense0.30%0.23%0.35%0.61%0.60%
Receive EYEG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AB Corporate Bond ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EYEG ETF News Headlines

AB Corporate Bond ETF (NASDAQ:EYEG) Stock Short Interest Report for September
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel
AB Corporate Bond ETF declares $0.1358 dividend
See More Headlines

EYEG ETF - Frequently Asked Questions

AB Corporate Bond ETF's stock was trading at $35.7910 at the start of the year. Since then, EYEG stock has decreased by 6.5% and is now trading at $33.46.

AB Corporate Bond ETF (NASDAQ:EYEG) announced its quarterly earnings results on Thursday, August, 12th. The specialty pharmaceutical company reported ($0.35) EPS for the quarter, beating the consensus estimate of ($0.42) by $0.07.

AB Corporate Bond ETF (EYEG) raised $5 million in an initial public offering (IPO) on Friday, February 13th 2015. The company issued 800,000 shares at a price of $6.00 per share. Aegis Capital Corp and Chardan Capital Markets acted as the underwriters for the IPO.

Shares of EYEG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AB Corporate Bond ETF investors own include Novavax (NVAX), ExxonMobil (XOM), Plus Therapeutics (PSTV), Celldex Therapeutics (CLDX), Cisco Systems (CSCO), Gevo (GEVO) and Alphabet (GOOG).

Fund Details

Issuer
AllianceBernstein
Fund Name
AB Corporate Bond ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:EYEG
Inception Date
12/12/2023
Fund Manager
Timothy Kurpis, Bernd Wuebben

Fund Focus

Asset Class
Fixed Income
Benchmark
N/A
Category
Corporate
Focus
Investment Grade
Development Level
Blended Development
Region
Global
Number of Holdings
313

Fund Statistics

Assets Under Management
$26.76 million
Average Daily Volume
$0.00
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
AllianceBernstein L.P.
Custodian
State Street Bank and Trust Company
Distributor
Foreside Fund Services, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Jane Street

Miscellaneous

Beta
0.20
Creation Unit
50,000
Creation Fee
$250.00
7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Top 10 EYEG Holdings

  • Us Long Bond(Cbt) Dec26 Xcbt 20261221
    Holding Weight: 9.11%
  • Alliancebernstein Govt Stif Ssc Fund 64ba Agis 587
    Holding Weight: 1.53%
  • Us 10yr Note (Cbt)dec26 Xcbt 20261221
    Holding Weight: 0.77%
  • Us Dollar
    Holding Weight: 0.60%
  • AbbVie Inc. 4.8%
    Holding Weight: 0.52%
  • Archer-Daniels-Midland Co. 3.25%
    Holding Weight: 0.52%
  • Barrick (PD) Australia Finance Pty Ltd 5.95%
    Holding Weight: 0.52%
  • ConocoPhillips 6.5%
    Holding Weight: 0.52%
  • Dollar Tree Inc 4.2%
    Holding Weight: 0.52%
  • Fortune Brands Innovations Inc 3.25%
    Holding Weight: 0.52%

This page (NASDAQ:EYEG) was last updated on 10/13/2026 by MarketBeat.com Staff.
From Our Partners